Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist. (Q48253003)

10 February 2018

title

Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist. (English)

1 reference

10 February 2018

1 reference

M Poncelet

1

1 reference

10 February 2018

M Arnone

2

1 reference

10 February 2018

M Heaulme

3

1 reference

10 February 2018

N Gonalons

4

1 reference

10 February 2018

C Gueudet

5

1 reference

10 February 2018

V Santucci

6

1 reference

10 February 2018

O Thurneyssen

7

1 reference

10 February 2018

P Keane

8

1 reference

10 February 2018

D Gully

9

1 reference

10 February 2018

G Le Fur

10

1 reference

10 February 2018

publication date

1 July 1993

1 reference

10 February 2018

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

10 February 2018

volume

348

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

102-107

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00168544

exact match

0 references

cites work

Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.

1 reference

12 December 2020

Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.

1 reference

12 December 2020

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

1 reference

12 December 2020

Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons

1 reference

12 December 2020

Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice

1 reference

12 December 2020

Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK

1 reference

12 December 2020

Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin

1 reference

12 December 2020

Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.

1 reference

12 December 2020

Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide

1 reference

12 December 2020

The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons

1 reference

12 December 2020

Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the Rat

1 reference

12 December 2020

Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype.

1 reference

12 December 2020

Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors

1 reference

12 December 2020

Evidence for a physiological role for CCK in the regulation of food intake in mice.

1 reference

12 December 2020

Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology

1 reference

12 December 2020

Inhibition of climbing and mossy fiber input to mouse cerebellar Purkinje cells by cholecystokinin

1 reference

12 December 2020

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

12 December 2020

Cholecystokinin antianalgesia: safety cues abolish morphine analgesia

1 reference

12 December 2020

Distinct cholecystokinin receptors in brain and pancreas

1 reference

12 December 2020

Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists

1 reference

12 December 2020

The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin

1 reference

12 December 2020

Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors

1 reference

12 December 2020

L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.

1 reference

12 December 2020

Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: pharmacological analysis of a simple screening model

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Functional role of brain CCK receptors

1 reference

12 December 2020

Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides

1 reference

12 December 2020

Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons

1 reference

12 December 2020

Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors

1 reference

12 December 2020

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00168544

1 reference

10 February 2018

release_4n3xg445irhk5ktz7frjjclcme

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4n3xg445irhk5ktz7frjjclcme

24 November 2022

mapped directly with Wikidata item

PubMed ID

8397341

1 reference

10 February 2018